Check out the latest study from @McGettrickLab
Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss: Cell Reports Medicine https://t.co/GYoXYRexIQ
Our latest collaborative effort with @immuno_pharma published in J of Autoimmunity
A reverse translational approach reveals the protective roles of Mangi... https://t.co/pWATQVsD77
I had the fantastic opportunity of co-chairing the final plenary session for @bsicongress in belfast today thanks to @McGettrickLab and @DrAJIqbal for the possibility to attend #BSI23
BRC researchers @DrAJIqbal, @TariqFMT & @McGettrickLab are partnering with @Roche to investigate how inflammatory bowel disease (#IBD) develops in relation to the types of macrophages in the intestine, with a view to developing new treatments for patients: https://t.co/chx8abtOUF
Il-17 story. Today our scientific work has just been accepted by the J An.of the RheDis(IF:27.5) in which a new biologic (Ab-IPL-IL17™) for IL-17-mediated diseases has been characterized by our group. It's a small step toward identifying innovative therapies for Autoim.Diseases
Check out our latest work! @Chimen_lab@McGettrickLab @ICVS_UoB
Aging modulates homeostatic leukocyte trafficking to the peritoneal cavity in a sex-specific manner https://t.co/c2c23j8DFJ
Research shows the peptide called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases: https://t.co/2iWW9woXRO. Read the paper: https://t.co/OJiBjP28CD @news_UB @unibirm_MDS @InflamAge_UoB@DrAJIqbal#obesity
What a way to end an amazing few days! Very honoured to have recieved an Oral Communications Award for my (first ever!) conference talk. Very proud of @JenefaBegum and @Yeebba1 for winning Poster Awards - big wins for #LeukocyteTraffickingGroup @ICVS_UoB @InflamAge_UoB#wci2022